{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:27:24Z","timestamp":1785940044826,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["82270177"],"award-info":[{"award-number":["82270177"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the China Medicine Education Association 2024 Medical Science and Technology Research Project","award":["2024KTZ035"],"award-info":[{"award-number":["2024KTZ035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11596-025-00042-2","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:45:45Z","timestamp":1745415945000},"page":"458-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting Calprotectin S100A8\/A9 to Overcome AML Progression in DNMT3A-Mutant Cells"],"prefix":"10.1007","volume":"45","author":[{"given":"Xiao-ya","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-2642","authenticated-orcid":false,"given":"Deng-ju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"1","key":"42_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","volume":"51","author":"SA Assi","year":"2019","unstructured":"Assi SA, Imperato MR, Coleman DJL, et al. Subtype-specific regulatory network rewiring in acute myeloid leukemia. Nat Genet. 2019;51(1):151\u2013162.","journal-title":"Nat Genet."},{"issue":"4","key":"42_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u2013447.","journal-title":"Blood."},{"key":"42_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.critrevonc.2016.12.004","volume":"110","author":"G Tamamyan","year":"2017","unstructured":"Tamamyan G, Kadia T, Ravandi F, et al. Frontline treatment of acute myeloid leukemia in adults. Crit Rev Oncol Hematol. 2017;110:20\u201334.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"2","key":"42_CR4","doi-asserted-by":"publisher","first-page":"a030320","DOI":"10.1101\/cshperspect.a030320","volume":"7","author":"L Brunetti","year":"2017","unstructured":"Brunetti L, Gundry MC, Goodell MA. DNMT3A in Leukemia. Cold Spring Harb Perspect Med. 2017;7(2):a030320.","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"2","key":"42_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/0008-5472.CAN-20-3033","volume":"81","author":"K Venugopal","year":"2021","unstructured":"Venugopal K, Feng Y, Shabashvili D, et al. Alterations to DNMT3A in Hematologic Malignancies. Cancer Res. 2021;81(2):254\u2013263.","journal-title":"Cancer Res."},{"issue":"15","key":"42_CR6","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1182\/bloodadvances.2020001920","volume":"4","author":"MA Sekeres","year":"2020","unstructured":"Sekeres MA, Guyatt G, Abel G, et al. American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. Blood Adv. 2020;4(15):3528\u20133549.","journal-title":"Blood Adv."},{"issue":"12","key":"42_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","volume":"366","author":"JP Patel","year":"2012","unstructured":"Patel JP, G\u00f6nen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366(12):1079\u20131089.","journal-title":"N Engl J Med."},{"issue":"23","key":"42_CR8","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1182\/blood-2012-10-461624","volume":"121","author":"VI Gaidzik","year":"2013","unstructured":"Gaidzik VI, Schlenk RF, Paschka P, et al. Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). Blood. 2013;121(23):4769\u20134777.","journal-title":"Blood."},{"issue":"9","key":"42_CR9","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2352-3026(18)30132-7","volume":"5","author":"TM Kadia","year":"2018","unstructured":"Kadia TM, Cortes J, Ravandi F, et al. Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial. Lancet Haematol. 2018;5(9):e411-e421.","journal-title":"Lancet Haematol."},{"issue":"4","key":"42_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/ng.788","volume":"43","author":"XJ Yan","year":"2011","unstructured":"Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43(4):309\u2013315.","journal-title":"Nat Genet."},{"issue":"4","key":"42_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-Germain","year":"2014","unstructured":"Russler-Germain DA, Spencer DH, Young MA, et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell. 2014;25(4):442\u2013454.","journal-title":"Cancer Cell."},{"issue":"2","key":"42_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/leu.2017.295","volume":"32","author":"SK Balasubramanian","year":"2018","unstructured":"Balasubramanian SK, Aly M, Nagata Y, et al. Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms. Leukemia. 2018;32(2):550\u2013553.","journal-title":"Leukemia."},{"issue":"2","key":"42_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.apsb.2021.09.015","volume":"12","author":"M Liao","year":"2022","unstructured":"Liao M, Chen R, Yang Y, et al. Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis. Acta Pharm Sin B. 2022;12(2):678\u2013691.","journal-title":"Acta Pharm Sin B."},{"key":"42_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653030","volume":"12","author":"Y Que","year":"2021","unstructured":"Que Y, Li H, Lin L, et al. Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation. Front Immunol. 2021;12:653030.","journal-title":"Front Immunol."},{"issue":"10","key":"42_CR15","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/s41375-019-0504-y","volume":"33","author":"R Karjalainen","year":"2019","unstructured":"Karjalainen R, Liu M, Kumar A, et al. Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML. Leukemia. 2019;33(10):2548\u20132553.","journal-title":"Leukemia."},{"key":"42_CR16","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, et al. S100A8\/A9 in Inflammation. Front Immunol. 2018;9:1298.","journal-title":"Front Immunol."},{"issue":"8","key":"42_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/1535370216681551","volume":"242","author":"F Ometto","year":"2017","unstructured":"Ometto F, Friso L, Astorri D, et al. Calprotectin in rheumatic diseases. Exp Biol Med (Maywood). 2017;242(8):859\u2013873.","journal-title":"Exp Biol Med (Maywood)."},{"issue":"3","key":"42_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/0363546517741127","volume":"46","author":"JZB Cher","year":"2018","unstructured":"Cher JZB, Akbar M, Kitson S, et al. Alarmins in Frozen Shoulder: A Molecular Association Between Inflammation and Pain. Am J Sports Med. 2018;46(3):671\u2013678.","journal-title":"Am J Sports Med."},{"issue":"11","key":"42_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11882-018-0817-3","volume":"18","author":"S Patel","year":"2018","unstructured":"Patel S. Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation. Curr Allergy Asthma Rep. 2018;18(11):63.","journal-title":"Curr Allergy Asthma Rep."},{"issue":"8","key":"42_CR20","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/s41375-019-0397-9","volume":"33","author":"P Cheng","year":"2019","unstructured":"Cheng P, Eksioglu EA, Chen X, et al. S100A9-induced overexpression of PD-1\/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes. Leukemia. 2019;33(8):2034\u20132046.","journal-title":"Leukemia."},{"issue":"1","key":"42_CR21","doi-asserted-by":"publisher","first-page":"11220","DOI":"10.1038\/s41598-021-90794-3","volume":"11","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Chen X, Li Z, et al. Overexpression of S100A9 in tumor stroma contribute to immune evasion of NK\/T cell lymphoma and predict poor response rate. Sci Rep. 2021;11(1):11220.","journal-title":"Sci Rep."},{"issue":"27","key":"42_CR22","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1038\/sj.onc.1205521","volume":"21","author":"C Gebhardt","year":"2002","unstructured":"Gebhardt C, Breitenbach U, Tuckermann JP, et al. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene. 2002;21(27):4266\u20134276.","journal-title":"Oncogene."},{"issue":"3","key":"42_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188891","volume":"1878","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ouyang Y, Li Z, et al. S100A8 and S100A9 in Cancer. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188891.","journal-title":"Biochim Biophys Acta Rev Cancer."},{"issue":"6","key":"42_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.chom.2023.04.018","volume":"31","author":"W Liang","year":"2023","unstructured":"Liang W, Yang Y, Gong S, et al. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host Microbe. 2023;31(6):1054\u20131070.e1059.","journal-title":"Cell Host Microbe."},{"issue":"1","key":"42_CR25","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1038\/s41467-023-38842-6","volume":"14","author":"X Feng","year":"2023","unstructured":"Feng X, Wang L, Zhou R, et al. Senescent immune cells accumulation promotes brown adipose tissue dysfunction during aging. Nat Commun. 2023;14(1):3208.","journal-title":"Nat Commun."},{"issue":"17","key":"42_CR26","doi-asserted-by":"publisher","first-page":"13382","DOI":"10.3390\/ijms241713382","volume":"24","author":"F Razmkhah","year":"2023","unstructured":"Razmkhah F, Kim S, Lim S, et al. S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy. Int J Mol Sci. 2023;24(17):13382.","journal-title":"Int J Mol Sci."},{"issue":"7488","key":"42_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush LI, Zandi S, Mitchell A, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506(7488):328\u2013333.","journal-title":"Nature."},{"issue":"9","key":"42_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41577-023-00843-3","volume":"23","author":"R Belizaire","year":"2023","unstructured":"Belizaire R, Wong WJ, Robinette ML, et al. Clonal haematopoiesis and dysregulation of the immune system. Nat Rev Immunol. 2023;23(9):595\u2013610.","journal-title":"Nat Rev Immunol."},{"issue":"10","key":"42_CR29","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1111\/cas.15094","volume":"112","author":"S Asada","year":"2021","unstructured":"Asada S, Kitamura T. Clonal hematopoiesis and associated diseases: A review of recent findings. Cancer Sci. 2021;112(10):3962\u20133971.","journal-title":"Cancer Sci."},{"issue":"9","key":"42_CR30","doi-asserted-by":"publisher","first-page":"e163864","DOI":"10.1172\/jci.insight.163864","volume":"8","author":"LR Palam","year":"2023","unstructured":"Palam LR, Ramdas B, Pickerell K, et al. Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway. JCI Insight. 2023;8(9):e163864.","journal-title":"JCI Insight."},{"key":"42_CR31","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1038\/ncomms7915","volume":"6","author":"M Pruenster","year":"2015","unstructured":"Pruenster M, Kurz AR, Chung KJ, et al. Extracellular MRP8\/14 is a regulator of \u03b22 integrin-dependent neutrophil slow rolling and adhesion. Nat Commun. 2015;6:6915.","journal-title":"Nat Commun."},{"key":"42_CR32","doi-asserted-by":"publisher","first-page":"1365015","DOI":"10.3389\/fimmu.2024.1365015","volume":"15","author":"G De Luca","year":"2024","unstructured":"De Luca G, Goette NP, Lev PR, et al. Elevated levels of damage-associated molecular patterns HMGB1 and S100A8\/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis. Front Immunol. 2024;15:1365015.","journal-title":"Front Immunol."},{"issue":"3","key":"42_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10059-013-2269-x","volume":"35","author":"CH Kwon","year":"2013","unstructured":"Kwon CH, Moon HJ, Park HJ, et al. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-\u03baB activation in gastric cancer cells. Mol Cells. 2013;35(3):226\u2013234.","journal-title":"Mol Cells."},{"issue":"11","key":"42_CR34","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.4049\/jimmunol.1402301","volume":"194","author":"K Narumi","year":"2015","unstructured":"Narumi K, Miyakawa R, Ueda R, et al. Proinflammatory Proteins S100A8\/S100A9 Activate NK Cells via Interaction with RAGE. J Immunol. 2015;194(11):5539\u20135548.","journal-title":"J Immunol."},{"issue":"6","key":"42_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-0030-1268426","volume":"119","author":"K Eggers","year":"2011","unstructured":"Eggers K, Sikora K, Lorenz M, et al. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1. Exp Clin Endocrinol Diabetes. 2011;119(6):353\u2013357.","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"11","key":"42_CR36","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/onc.2015.211","volume":"35","author":"A Deguchi","year":"2016","unstructured":"Deguchi A, Tomita T, Ohto U, et al. Eritoran inhibits S100A8-mediated TLR4\/MD-2 activation and tumor growth by changing the immune microenvironment. Oncogene. 2016;35(11):1445\u20131456.","journal-title":"Oncogene."},{"issue":"2","key":"42_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15(2):96\u2013109.","journal-title":"Nat Rev Cancer."},{"issue":"35","key":"42_CR38","doi-asserted-by":"publisher","first-page":"56798","DOI":"10.18632\/oncotarget.10792","volume":"7","author":"K Liu","year":"2016","unstructured":"Liu K, Zhang Y, Zhang C, et al. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma. Oncotarget. 2016;7(35):56798\u201356810.","journal-title":"Oncotarget."},{"issue":"1","key":"42_CR39","doi-asserted-by":"publisher","first-page":"13298","DOI":"10.1038\/s41598-024-61728-6","volume":"14","author":"W Zeng","year":"2024","unstructured":"Zeng W, Gao Y, Wang Q, et al. Preliminary clinical analysis and pathway study of S100A8 as a biomarker for the diagnosis of acute deep vein thrombosis. Sci Rep. 2024;14(1):13298.","journal-title":"Sci Rep."},{"issue":"4","key":"42_CR40","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/ijms.37833","volume":"17","author":"DH Kim","year":"2020","unstructured":"Kim DH, Gu A, Lee JS, et al. Suppressive effects of S100A8 and S100A9 on neutrophil apoptosis by cytokine release of human bronchial epithelial cells in asthma. Int J Med Sci. 2020;17(4):498\u2013509.","journal-title":"Int J Med Sci."},{"key":"42_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151023","volume":"741","author":"S Wang","year":"2024","unstructured":"Wang S, Wang Y, Wang S, et al. Single-cell RNA sequencing reveals S100A8\/A9(hi) neutrophils-induced endothelial cell death and lymphocyte infiltration after ischemic stroke. Biochem Biophys Res Commun. 2024;741:151023.","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"42_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/hon.2707","volume":"38","author":"J Mondet","year":"2020","unstructured":"Mondet J, Laurin D, Lo Presti C, et al. Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients. Hematol Oncol. 2020;38(1):114\u2013118.","journal-title":"Hematol Oncol."},{"issue":"1","key":"42_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/leu.2010.251","volume":"25","author":"E Nicolas","year":"2011","unstructured":"Nicolas E, Ramus C, Berthier S, et al. Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients. Leukemia. 2011;25(1):57\u201365.","journal-title":"Leukemia."},{"key":"42_CR44","doi-asserted-by":"publisher","first-page":"5742954","DOI":"10.1155\/2018\/5742954","volume":"2018","author":"HJS Stewart","year":"2018","unstructured":"Stewart HJS, Chaudry S, Crichlow A, et al. BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death. Bone Marrow Res. 2018;2018:5742954.","journal-title":"Bone Marrow Res."},{"issue":"1","key":"42_CR45","first-page":"83","volume":"19","author":"L Yang","year":"2020","unstructured":"Yang L, Li D, Tang P, et al. Curcumin increases the sensitivity of K562\/DOX cells to doxorubicin by targeting S100 calcium-binding protein A8 and P-glycoprotein. Oncol Lett. 2020;19(1):83\u201392.","journal-title":"Oncol Lett."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00042-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:03:34Z","timestamp":1751875414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00042-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00042-2","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors have been informed about this manuscript and have consented to its publication. Each author agrees that this work is ready for publication and accepts responsibility for its contents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}